U.S. Patent disclosures
Tuesday, May 27, 2014
Alzheon Inc., of Lexington, Mass., received a notice of allowance for U.S. Patent application No. 11/871,639, "Methods, Compounds, Compositions and Vehicles for Delivering 3-Amino-1-Propanesulfonic Acid," for its lead therapeutic candidate ALZ-801. ALZ-801 is in a pivotal phase II/III study in Alzheimer's disease patients positive for ε4 allele of the apolipoprotein E.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.